Invst LLC Takes $847,000 Position in Philip Morris International Inc. $PM

Invst LLC bought a new stake in Philip Morris International Inc. (NYSE:PMFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,681 shares of the company’s stock, valued at approximately $847,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PM. Brighton Jones LLC boosted its position in Philip Morris International by 31.1% in the fourth quarter. Brighton Jones LLC now owns 8,531 shares of the company’s stock valued at $1,027,000 after buying an additional 2,023 shares during the last quarter. Revolve Wealth Partners LLC raised its position in Philip Morris International by 4.5% during the 4th quarter. Revolve Wealth Partners LLC now owns 2,097 shares of the company’s stock worth $252,000 after buying an additional 91 shares during the last quarter. Sivia Capital Partners LLC raised its position in Philip Morris International by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 5,636 shares of the company’s stock worth $1,027,000 after buying an additional 1,970 shares during the last quarter. Jump Financial LLC acquired a new stake in Philip Morris International during the 2nd quarter valued at approximately $2,454,000. Finally, Osterweis Capital Management Inc. lifted its stake in Philip Morris International by 2,280.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 357 shares of the company’s stock valued at $65,000 after acquiring an additional 342 shares during the period. Hedge funds and other institutional investors own 78.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on PM shares. Bank of America reissued a “buy” rating on shares of Philip Morris International in a report on Thursday, May 21st. BTIG Research set a $221.00 price target on shares of Philip Morris International and gave the company a “buy” rating in a report on Friday, July 24th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Philip Morris International in a research report on Monday, August 17th. Barclays lifted their price objective on Philip Morris International from $205.00 to $225.00 and gave the company an “overweight” rating in a research note on Wednesday, July 29th. Finally, Morgan Stanley boosted their price objective on Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Ten investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $205.89.

Check Out Our Latest Stock Report on PM

Key Philip Morris International News

Here are the key news stories impacting Philip Morris International this week:

  • Positive Sentiment: FDA authorization strengthens ZYN growth prospects. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term shift away from combustible tobacco. Smoke-free products, led by ZYN and IQOS, now account for more than 41% of revenue, offering a potential multiyear growth runway. Philip Morris’ ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
  • Positive Sentiment: Manufacturing agreements with Altria may improve efficiency. PM and Altria entered reciprocal contract-manufacturing arrangements involving cigarette production. The agreements should increase operational flexibility and manufacturing efficiency, with initial shipments expected in 2027. The partnership may provide longer-term cost and supply-chain benefits for PM, despite limited near-term earnings impact. Altria and Philip Morris International Sign Contract Manufacturing Deals
  • Positive Sentiment: Pricing power and shareholder returns remain supportive. PM’s portfolio spans IQOS, ZYN, VEEV One, and Marlboro, helping it maintain premium pricing amid uncertain economic conditions. Analysts highlight strong free cash flow, lower debt leverage, and the possibility of another dividend increase in September. Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets
  • Neutral Sentiment: Near-term financial impact from the Altria deal is expected to be limited. Both companies said the manufacturing arrangements are not expected to materially affect 2026 results, so investors may need to wait until 2027 for measurable benefits. Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
  • Negative Sentiment: Valuation leaves less room for disappointment. PM’s smoke-free growth and defensive cash flows have attracted a premium valuation, creating downside risk if product adoption, regulatory momentum, or earnings growth falls short of expectations.

Philip Morris International Price Performance

NYSE:PM opened at $194.00 on Wednesday. The company has a 50 day moving average price of $186.42 and a 200-day moving average price of $178.55. Philip Morris International Inc. has a 1-year low of $142.11 and a 1-year high of $207.76. The firm has a market cap of $302.36 billion, a price-to-earnings ratio of 27.87, a price-to-earnings-growth ratio of 2.31 and a beta of 0.38.

Philip Morris International (NYSE:PMGet Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.05 by $0.15. The firm had revenue of $11.19 billion for the quarter, compared to the consensus estimate of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, sell-side analysts anticipate that Philip Morris International Inc. will post 8.33 earnings per share for the current fiscal year.

Philip Morris International Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were paid a $1.47 dividend. This represents a $5.88 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Thursday, June 25th. Philip Morris International’s payout ratio is currently 84.48%.

About Philip Morris International

(Free Report)

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Further Reading

Institutional Ownership by Quarter for Philip Morris International (NYSE:PM)

Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.